Literature DB >> 32740172

National organization of uterine cervical cancer screening and social inequality in France.

Thibaut Raginel1,2, Rémy de Mil2, Anne Garnier3, Guy Launoy2, Lydia Guittet2.   

Abstract

Some of the inequality in uterine cervical cancer (UCC) screening uptake are due to the socioeconomic deprivation of women. A national organized screening programme has proven to be effective in increasing the uptake, but may increase socioeconomic inequality. Therefore, we compared inequality in uptake of UCC screening between two French departments, one of which is experimenting an organized screening programme. We used reimbursement data from the main French health insurance scheme to compare screening rates in the municipalities of the two departments over a three-year period. The experimental department had higher screening rates, but the increase in deprivation in municipalities had a greater effect on the decrease in participation in this department. Moreover, while screening rates were higher in urban areas, the negative effect of deprivation on participation was greater in rural areas. Although these departments were compared at the same time under different conditions, socioeconomic inequality between them may have been greater before the experimentation started. However, screening may have led to an increase in socioeconomic inequality between women screened. Special attention must be paid to changes in socioeconomic and geographic inequality in the uptake of UCC screening when the programme is rolled out nationally.

Entities:  

Year:  2020        PMID: 32740172     DOI: 10.1097/CEJ.0000000000000557

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  1 in total

1.  Social and territorial inequalities in breast and cervical cancers screening uptake: a cross-sectional study in France.

Authors:  Cyrille Delpierre; Pascale Grosclaude; Lisa Ouanhnon; Marie-Eve Rougé Bugat; Sebastien Lamy; Vladimir Druel
Journal:  BMJ Open       Date:  2022-02-22       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.